| Telomere maintenance mechanisms define clinical outcome in high-risk neuroblastoma B Koneru, G Lopez, A Farooqi, KL Conkrite, TH Nguyen, SJ Macha, ... Cancer research 80 (12), 2663-2675, 2020 | 72 | 2020 |
| ALT neuroblastoma chemoresistance due to telomere dysfunction–induced ATM activation is reversible with ATM inhibitor AZD0156 B Koneru, A Farooqi, TH Nguyen, WH Chen, A Hindle, C Eslinger, ... Science translational medicine 13 (607), eabd5750, 2021 | 40 | 2021 |
| Reactive oxygen species–mediated synergism of fenretinide and romidepsin in preclinical models of T-cell lymphoid malignancies MR Makena, B Koneru, TH Nguyen, MH Kang, CP Reynolds Molecular cancer therapeutics 16 (4), 649-661, 2017 | 37 | 2017 |
| Distinguishing immune activation and inflammatory signatures of multisystem inflammatory syndrome in children (MIS-C) versus hemophagocytic lymphohistiocytosis (HLH) D Kumar, CA Rostad, P Jaggi, DSV Nunez, C Prince, A Lu, L Hussaini, ... Journal of Allergy and Clinical Immunology 149 (5), 1592-1606. e16, 2022 | 28 | 2022 |
| MYC transcription activation mediated by OCT4 as a mechanism of resistance to 13-cisRA-mediated differentiation in neuroblastoma SJ Wei, TH Nguyen, IH Yang, DG Mook, MR Makena, D Verlekar, ... Cell death & disease 11 (5), 368, 2020 | 23 | 2020 |
| Fenretinide via NOXA induction, enhanced activity of the BCL-2 inhibitor venetoclax in high BCL-2-expressing neuroblastoma preclinical models TH Nguyen, B Koneru, SJ Wei, WH Chen, MR Makena, E Urias, MH Kang, ... Molecular cancer therapeutics, molcanther. 0385.2019, 2019 | 18 | 2019 |
| Cytotoxicity and molecular activity of fenretinide and metabolites in T-cell lymphoid malignancy, neuroblastoma, and ovarian cancer cell lines in physiological hypoxia MM Song, MR Makena, A Hindle, B Koneru, TH Nguyen, DU Verlekar, ... Anti-Cancer Drugs 30 (2), 117-127, 2019 | 13 | 2019 |
| Vorinostat and fenretinide synergize in preclinical models of T-cell lymphoid malignancies MR Makena, TH Nguyen, B Koneru, A Hindle, WH Chen, DU Verlekar, ... Anti-Cancer Drugs 32 (1), 34-43, 2021 | 11* | 2021 |
| Frequency of HLA-DR+ CD38hi T cells identifies and quantifies T-cell activation in hemophagocytic lymphohistiocytosis, hyperinflammation, and immune regulatory disorders TH Nguyen, D Kumar, C Prince, D Martini, JR Grunwell, T Lawrence, ... Journal of Allergy and Clinical Immunology 153 (1), 309-319, 2024 | 6 | 2024 |
| The O6-methyguanine-DNA methyltransferase inhibitor O6-benzylguanine enhanced activity of temozolomide+ irinotecan against models of high-risk neuroblastoma A Hindle, B Koneru, MR Makena, L Lopez-Barcons, WH Chen, ... Anti-cancer drugs 32 (3), 233-247, 2021 | 6 | 2021 |
| Cytotoxic activity of difluoromethylornithine compared with fenretinide in neuroblastoma cell lines MR Makena, HE Cho, TH Nguyen, B Koneru, DU Verlekar, A Hindle, ... Pediatric blood & cancer 65 (12), e27447, 2018 | 6 | 2018 |
| Von Hippel-Lindau with early onset of hemangioblastoma and multiple drop-metastases like spinal lesions: A case report TH Nguyen, T Pham, T Strickland, D Brewer, M Belirgen, MM Al-Rahawan Medicine 97 (39), e12477, 2018 | 6 | 2018 |
| Sarcoma as second cancer in a childhood cancer survivor: case report, large population analysis and literature review TH Nguyen, MR Makena, S Yavvari, M Kaur, T Pham, E Urias, ... Medicina 56 (5), 224, 2020 | 5 | 2020 |
| mTOR inhibition attenuates cTfh cell dysregulation and chronic T-cell activation in multilineage immune cytopenias D Kumar, TH Nguyen, CM Bennett, C Prince, L Lucas, S Park, T Lawrence, ... Blood 141 (3), 238-243, 2023 | 4 | 2023 |
| Comparison of the cytotoxicity and increase of reactive oxygen species and dihydroceramides of fenretinide to its major metabolites (4-oxo-and 4-methoxyphenyl fenretinide) in T … MM Song, MR Makena, A Hindle, B Koneru, TH Nguyen, H Cho, ... Cancer Research 75 (15_Supplement), 2616-2616, 2015 | 3 | 2015 |
| User-Centered Design and Evaluation of Clinical Decision Support to Improve Early Peanut Introduction: Formative Study TH Nguyen, PP Cunha, AF Rowland, E Orenstein, T Lee, S Kandaswamy JMIR Formative Research 7 (1), e47574, 2023 | 1 | 2023 |
| DNA-PKcs as an upstream mediator of OCT4-induced MYC activation in small cell lung cancer SJ Wei, IH Yang, IS Mohiuddin, GJ Kshirsagar, TH Nguyen, S Trasti, ... Biochimica et Biophysica Acta (BBA)-Gene Regulatory Mechanisms 1866 (2), 194939, 2023 | 1 | 2023 |
| ALT Neuroblastoma Chemoresistance due to ATM Activation by Telomere Dysfunction is Reversible with the ATM Inhibitor AZD0156 B Koneru, A Farooqi, TH Nguyen, WH Chen, A Hindle, C Eslinger, ... bioRxiv, 2021.04. 06.438692, 2021 | 1 | 2021 |
| Evaluating Clinical Decision Support Tool for Early Peanut Introduction in a Pediatric Continuity Clinic A Rowland, T Nguyen, P Cunha, S Kandaswamy, T Lee Journal of Allergy and Clinical Immunology 153 (2), AB236, 2024 | | 2024 |
| The utility of HLA-DR+ CD38high expression in quantifying the amplitude of T cell activation in HLH and immune dysregulation disorders T Nguyen, D Kumar, C Prince, S Prahalad, M Briones, S Chandrakasan Clinical Immunology 250, 109567, 2023 | | 2023 |
Monish Ram MakenaNational Institute of Health在 nih.gov 的电子邮件经过验证
Monish Ram MakenaNational Institute of Health在 nih.gov 的电子邮件经过验证